Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Elasticity Imaging Techniques | 26 | 2025 | 109 | 3.610 |
Why?
|
| Tomography, Optical Coherence | 21 | 2025 | 217 | 1.830 |
Why?
|
| Cornea | 17 | 2025 | 140 | 1.500 |
Why?
|
| Animals | 24 | 2025 | 1711 | 0.670 |
Why?
|
| Biomechanical Phenomena | 14 | 2024 | 154 | 0.650 |
Why?
|
| Elastic Modulus | 8 | 2025 | 30 | 0.570 |
Why?
|
| Elasticity | 5 | 2024 | 40 | 0.550 |
Why?
|
| Skin | 3 | 2025 | 26 | 0.470 |
Why?
|
| Scleroderma, Systemic | 2 | 2025 | 8 | 0.380 |
Why?
|
| Mice | 9 | 2025 | 685 | 0.350 |
Why?
|
| Riboflavin | 4 | 2020 | 25 | 0.330 |
Why?
|
| Lens, Crystalline | 2 | 2024 | 34 | 0.320 |
Why?
|
| Tonometry, Ocular | 5 | 2024 | 39 | 0.300 |
Why?
|
| Collagen | 5 | 2022 | 34 | 0.270 |
Why?
|
| Microscopy, Confocal | 2 | 2024 | 49 | 0.270 |
Why?
|
| Swine | 6 | 2024 | 50 | 0.240 |
Why?
|
| Fibrosis | 1 | 2025 | 12 | 0.230 |
Why?
|
| Rabbits | 6 | 2025 | 39 | 0.230 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 225 | 0.230 |
Why?
|
| Transforming Growth Factor beta | 1 | 2024 | 10 | 0.220 |
Why?
|
| Tissue Scaffolds | 1 | 2024 | 8 | 0.220 |
Why?
|
| Phantoms, Imaging | 4 | 2025 | 83 | 0.210 |
Why?
|
| Neural Tube | 1 | 2024 | 4 | 0.210 |
Why?
|
| Neurulation | 1 | 2024 | 4 | 0.210 |
Why?
|
| Rhombencephalon | 1 | 2024 | 7 | 0.210 |
Why?
|
| Keratomileusis, Laser In Situ | 1 | 2024 | 4 | 0.210 |
Why?
|
| Eye Diseases | 1 | 2024 | 16 | 0.200 |
Why?
|
| Female | 7 | 2025 | 2523 | 0.200 |
Why?
|
| Algorithms | 2 | 2015 | 241 | 0.190 |
Why?
|
| Hyaluronic Acid | 1 | 2022 | 4 | 0.190 |
Why?
|
| Alcohol Drinking | 1 | 2024 | 102 | 0.190 |
Why?
|
| Cross-Linking Reagents | 3 | 2018 | 15 | 0.190 |
Why?
|
| Ultraviolet Rays | 3 | 2018 | 29 | 0.190 |
Why?
|
| Burns, Chemical | 1 | 2022 | 4 | 0.190 |
Why?
|
| Photosensitizing Agents | 2 | 2018 | 8 | 0.170 |
Why?
|
| Pelvic Floor | 1 | 2020 | 2 | 0.170 |
Why?
|
| Limbus Corneae | 1 | 2020 | 6 | 0.170 |
Why?
|
| Anterior Eye Segment | 1 | 2020 | 12 | 0.170 |
Why?
|
| Multimodal Imaging | 1 | 2019 | 4 | 0.150 |
Why?
|
| Liver | 1 | 2020 | 49 | 0.150 |
Why?
|
| Mitral Valve | 1 | 2019 | 6 | 0.150 |
Why?
|
| Humans | 7 | 2025 | 4936 | 0.130 |
Why?
|
| Rose Bengal | 1 | 2016 | 4 | 0.120 |
Why?
|
| Intraocular Pressure | 3 | 2022 | 62 | 0.120 |
Why?
|
| Embryo, Mammalian | 2 | 2024 | 30 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 2 | 2025 | 184 | 0.100 |
Why?
|
| Mice, Knockout | 2 | 2024 | 140 | 0.100 |
Why?
|
| Aging | 1 | 2015 | 109 | 0.100 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2024 | 68 | 0.090 |
Why?
|
| Pregnancy | 2 | 2024 | 89 | 0.090 |
Why?
|
| Adult | 3 | 2025 | 1567 | 0.090 |
Why?
|
| Male | 3 | 2025 | 2491 | 0.080 |
Why?
|
| Heart Rate | 2 | 2021 | 43 | 0.080 |
Why?
|
| Young Adult | 2 | 2025 | 787 | 0.070 |
Why?
|
| Feasibility Studies | 2 | 2020 | 48 | 0.070 |
Why?
|
| Transducers | 1 | 2024 | 9 | 0.060 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2024 | 10 | 0.060 |
Why?
|
| Quinolines | 1 | 2024 | 21 | 0.050 |
Why?
|
| Tissue Engineering | 1 | 2024 | 16 | 0.050 |
Why?
|
| Formates | 1 | 2024 | 3 | 0.050 |
Why?
|
| Formate-Tetrahydrofolate Ligase | 1 | 2024 | 3 | 0.050 |
Why?
|
| Methylenetetrahydrofolate Dehydrogenase (NADP) | 1 | 2024 | 3 | 0.050 |
Why?
|
| Neural Tube Defects | 1 | 2024 | 3 | 0.050 |
Why?
|
| Pyrazoles | 1 | 2024 | 19 | 0.050 |
Why?
|
| Ganglia | 1 | 2024 | 3 | 0.050 |
Why?
|
| Cranial Nerves | 1 | 2024 | 4 | 0.050 |
Why?
|
| Acoustics | 1 | 2023 | 7 | 0.050 |
Why?
|
| Iris | 1 | 2023 | 10 | 0.050 |
Why?
|
| Face | 1 | 2023 | 19 | 0.050 |
Why?
|
| Ethanol | 1 | 2024 | 45 | 0.050 |
Why?
|
| Mutation | 1 | 2024 | 132 | 0.050 |
Why?
|
| Alkalies | 1 | 2022 | 4 | 0.050 |
Why?
|
| Sus scrofa | 1 | 2020 | 6 | 0.040 |
Why?
|
| Finite Element Analysis | 1 | 2020 | 8 | 0.040 |
Why?
|
| Perineum | 1 | 2020 | 1 | 0.040 |
Why?
|
| Parturition | 1 | 2020 | 3 | 0.040 |
Why?
|
| Middle Aged | 1 | 2025 | 967 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2021 | 98 | 0.040 |
Why?
|
| Sound | 1 | 2020 | 3 | 0.040 |
Why?
|
| Chickens | 1 | 2020 | 22 | 0.040 |
Why?
|
| Sclera | 1 | 2020 | 57 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 318 | 0.040 |
Why?
|
| Observer Variation | 1 | 2019 | 16 | 0.040 |
Why?
|
| Models, Biological | 1 | 2020 | 124 | 0.040 |
Why?
|
| Disease Progression | 1 | 2019 | 59 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2019 | 81 | 0.040 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2018 | 20 | 0.040 |
Why?
|
| Osmolar Concentration | 1 | 2018 | 17 | 0.030 |
Why?
|
| Organ Size | 1 | 2018 | 29 | 0.030 |
Why?
|
| Corneal Stroma | 1 | 2018 | 17 | 0.030 |
Why?
|
| Corneal Diseases | 1 | 2016 | 10 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2016 | 32 | 0.030 |
Why?
|
| Keratoconus | 1 | 2016 | 76 | 0.030 |
Why?
|
| Viscosity | 1 | 2015 | 10 | 0.030 |
Why?
|